Patents Examined by Mary C. Lee
  • Patent number: 5420327
    Abstract: Hydrocarbyl bisphosphate compounds containing hindered aryl substituents in the phosphate groups can be formed by: (a) reacting a hindered phenol, e.g., xylenol, with a phosphorus oxytrihalide, e.g., phosphorus oxytrichloride, to form a reaction product mixture; and (b) combining the reaction product, without distillation of the product from the reaction product mixture, from (a) mixture with a hydrocarbyl diol, e.g., one containing a phenyl ring such as hydroquinone or resorcinol.
    Type: Grant
    Filed: September 10, 1993
    Date of Patent: May 30, 1995
    Assignee: Akzo Nobel N.V.
    Inventors: Danielle A. Bright, Ronald L. Pirrelli
  • Patent number: 5420326
    Abstract: Bis(pentaerythritol phosphate alcohol) hydrogen phosphonate is a flame retardant compound. Such a compound can be prepared by the transesterification of a diphenyl phosphite with pentaerythritol phosphate alcohol.
    Type: Grant
    Filed: May 12, 1994
    Date of Patent: May 30, 1995
    Assignee: Akzo Nobel N.V.
    Inventor: Jeffrey E. Telschow
  • Patent number: 5420155
    Abstract: A class of 4-hydroxy-2(1H)-pyrrolone derivatives, substituted at the 3-position by an optionally substituted aryl substituent, are selective non-competitive antagonists of NMDA receptors and/or are antagonists of AMPA receptors, and are therefore of utility in the treatment of conditions, such as neurodegenerative disorders, convulsions or schizophrenia, which require the administration of an NMDA and/or AMPA receptor antagonist.
    Type: Grant
    Filed: May 10, 1993
    Date of Patent: May 30, 1995
    Assignee: Merck Sharp & Dohme Ltd.
    Inventors: Janusz J. Kulagowski, Paul D. Leeson, Ian M. Mawer
  • Patent number: 5420328
    Abstract: Phsophonate esters can be synthesized in high yields by condensations of alcohols with methyl phosphonates followed by selective demethylation. The reaction is general, relativly insensitive to steric constraints of hindered phosphonic acids, and can also be carried out on a solid support to synthesize large collections of compounds to screen for pharmacological activity.
    Type: Grant
    Filed: September 9, 1993
    Date of Patent: May 30, 1995
    Assignee: Affymax Technologies, N.V.
    Inventor: David A. Campbell
  • Patent number: 5420257
    Abstract: A reactive dye comprising a 1,3,5-s-triazine group having a chromophoric group at two of the 2-, 4- and 6-positions and a substituent at the remaining 2-, 4- or 6-position selected from H, optionally substituted alkyl, optionally substituted phenyl, --CH(CO.sub.2 R.sup.1).sub.2, --NR.sup.1 SO.sub.2 R.sup.2, and --SO.sub.2 R.sup.2, wherein each R.sup.1 is H or alkyl and R.sup.2 is alkyl. The reactive dyes may be used for the coloration of textile materials.
    Type: Grant
    Filed: September 17, 1993
    Date of Patent: May 30, 1995
    Assignee: Zeneca Limited
    Inventors: Kenneth Anderton, Andrew P. Shawcross
  • Patent number: 5420331
    Abstract: This invention provides a process for producing a cyclic carbonate compound represented by the following formula (5): ##STR1## or the like which is useful as a dissolution inhibitor for use in a chemically amplified positive photoresist, as well as a positive photoresist composition comprising said cyclic carbonate compound, an alkali-soluble resin and a photo-induced acid precursor. This composition gives a positive photoresist excellent in performances such as resolution, profile, sensitivity, etc.
    Type: Grant
    Filed: April 5, 1994
    Date of Patent: May 30, 1995
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Yuji Ueda, Naoki Takeyama, Hiromi Ueki, Takehiro Kusumoto
  • Patent number: 5416110
    Abstract: Benzyl derivatives of the formula I ##STR1## where A isCH.sub.2, CHCl, CH-alkyl, CH-alkoxy, CH-alkylthio or N-alkoxy,B isOH, alkylthio, alkoxy or alkylamino,U, V, W arehydrogen, halogen, alkyl or alkoxy,D is ##STR2## where R' ishydrogen or alkyl andR ishydrogen, alkyl, cycloalkyl, haloalkyl, halocycloalkyl, cycloalkylalkyl, alkoxyalkyl, alkylthioalkyl, arylthioalkyl, aryloxyalkyl, aryl, arylalkyl, hetaryl, hetaryl-alkyl, hetaryloxyalkyl or heterocyclyl, and fungicides containing these compounds.
    Type: Grant
    Filed: July 30, 1993
    Date of Patent: May 16, 1995
    Assignee: BASF Aktiengesellschaft
    Inventors: Horst Wingert, Hubert Sauter, Eberhard Ammermann, Gisela Lorenz
  • Patent number: 5414105
    Abstract: Disclosed herein are an azole derivative represented by the formula (I): ##STR1## wherein R.sup.1 and R.sup.2 respectively represent a (C.sub.1 -C.sub.5) alkyl group or a hydrogen atom; X represents a halogen atom, a (C.sub.1-C.sub.5) alkyl group or a phenyl group; n represents an integer of from 0 to 2 and A represents a nitrogen atom or a CH, provided that R.sup.1 is not a hydrogen atom when R.sup.2 is a hydrogen atom, a process for producing the azole derivative represented by the formula (I), and an agricultural and horticultural composition containing the azole derivative represented by the formula (I).
    Type: Grant
    Filed: May 17, 1993
    Date of Patent: May 9, 1995
    Assignee: Kureha Kagaku Kogyo Kabushiki Kaisha
    Inventors: Satoru Kumazawa, Susumu Shimizu, Hiroyuki Enari, Atsushi Ito, Susumu Ikeda, Nobuo Sato, Toshihide Saishoji
  • Patent number: 5414033
    Abstract: Novel compounds of the formula I and formula II ##STR1## in which R and R.sub.1, independently of one another, are hydrogen or C.sub.1 -C.sub.4 alkyl or together with the carbon atom to which they are attached form a 3,4-dehydrocyclohexylidene ring,R.sub.2 is hydrogen, C.sub.1 -C.sub.8 alkyl or C.sub.5 -C.sub.6 cycloalkyl,R.sub.3 is C.sub.1 -C.sub.8 alkyl or C.sub.5 -C.sub.6 cycloalkyl,R.sub.4, R.sub.5 and R.sub.6, independently of one another, are hydrogen or C.sub.1 -C.sub.4 alkyl, when alkyl, R.sub.4, R.sub.5 and R.sub.6 together containing 1 to 4 carbon atoms, andR.sub.7 and R.sub.8 are hydrogen or together an additional direct bond, are described for use as stabilizers for organic materials against thermal, oxidative or light-induced degradation.
    Type: Grant
    Filed: October 15, 1993
    Date of Patent: May 9, 1995
    Assignee: Ciba-Geigy Corporation
    Inventor: Peter Nesvadba
  • Patent number: 5414089
    Abstract: Provided is a long chain carboxylic acid imide ester (I) represented by the following general formula (I) ##STR1## wherein W is a divalent long chain hydrocarbon group which may optionally be interrupted by one or more groups each independently selected from the group consisting of an oxygen atom, a sulfur atom, and a group of --N(R.sup.1)-- (R.sup.1 being a lower alkyl group) and X represents a divalent hydrocarbon group which may optionally be substituted, or salts thereof. The above long chain carboxylic acid imide ester or its salts is useful for modifying enzymes or proteins having biological activities to give their derivatives which have, while retaining most of the original biological activities, an extremely prolonged plasma half-life as compared with the proteins and have no antigenecities and can be administered to animals.
    Type: Grant
    Filed: August 16, 1993
    Date of Patent: May 9, 1995
    Assignee: Kuraray Co., Ltd.
    Inventors: Iwao Ebashi, Tetsuo Takigawa, Masayasu Inoue
  • Patent number: 5414104
    Abstract: Dialkyl carbonates can be prepared by reaction of carbon monoxide with alkyl nitrites in a continuous gas-phase reaction using a platinum metal catalyst on a metal phosphate support and adding hydrogen halide stepwise or continuously during the course of the reaction in almost quantitative selectivity; the corresponding dialkyl oxalates are formed in such small amounts that in most cases they cannot be detected.
    Type: Grant
    Filed: April 22, 1994
    Date of Patent: May 9, 1995
    Assignee: Bayer Aktiengesellschaft
    Inventors: Joerg-Dietrich Jentsch, Alexander Klausener, Heinz Landscheidt, Erich Wolters, Eberhard Zirngiebl
  • Patent number: 5411960
    Abstract: Substituted pyrroloanthracenes are prepared by reacting either furanoanthracenes or N-unsubstituted pyrroloanthracenes with appropriately substituted alkylamines. The compounds can be employed as active ingredients in medicaments, in particular as immunomodulators.
    Type: Grant
    Filed: December 9, 1993
    Date of Patent: May 2, 1995
    Assignee: Bayer Aktiengesellschaft
    Inventors: Eckhard Schwenner, Gaetan Ladouceur, Hans-Joachim Kabbe, Thomas M. Aune
  • Patent number: 5411977
    Abstract: The present invention relates to substituted 2, 5-diaryl-4-isothiazolin-3-ones, pharmaceutical preparations containing them, and their use in the treatment of, thrombosis and, especially inflammation.
    Type: Grant
    Filed: March 31, 1993
    Date of Patent: May 2, 1995
    Assignee: The Dupont Merck Pharmaceutical Company
    Inventors: Joseph J. Petraitis, Susan R. Sherk
  • Patent number: 5412138
    Abstract: These acrylic and methacrylic compounds are chosen from those of the formula: ##STR1## in which R.sup.1 is H or CH.sub.3 ; A is (CH.sub.2).sub.n or n is an integer from 2 to 12 or --(CH.sub.2 CH.sub.2 O).sub.d --CH.sub.2 CH.sub.2 --, d is an integer from 1 to 20; X is S or O; Y is S or O, under the condition that X is S and Y is O when A is --(CH.sub.2 CH.sub.2 O).sub.d --CH.sub.2 CH.sub.2 --; R is C.sub.1 --C.sub.20 alkyl or --(CH.sub.2).sub.p SR.sup.3 where p is an integer from 3 to 12 and R.sup.3 is C.sub.1 -C.sub.20 -alkyl; m is an integer from 1 to 3; and Z is H, R.sup.2 QH, or R.sup.2 is C.sub.2 -C.sub.12 -alkyl and Q is O or S, and the atoms of the metals from Groups IA, IIA, IIIA, IB, IIB, VIB, VIIB and VIII of the Periodic Table, on condition that Z is H or R.sup.2 OH when m is 1 and m is the valence of Z when Z is a metal.
    Type: Grant
    Filed: December 14, 1992
    Date of Patent: May 2, 1995
    Assignee: Elf Atochem S.A.
    Inventors: Martine Cerf, Jean-Luc Mieloszynski, Daniel Paquer
  • Patent number: 5412102
    Abstract: The present invention relates to processes for preparing 1-butyl-2-[2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl]-1H-indole-3-carboxyli c acid and to intermediates useful in such processes. The present invention also relates to a process for deprotecting compounds containing a protected 2H-tetrazolyl group, which process comprises reacting a the protected compound with a Lewis acid in the presence of a thiol.
    Type: Grant
    Filed: May 27, 1994
    Date of Patent: May 2, 1995
    Assignee: Syntex (U.S.A.) Inc.
    Inventors: Robin D. Clark, Lawrence E. Fisher, Lee A. Flippin, Michael G. Martin, Stephen R. Stabler
  • Patent number: 5412078
    Abstract: The reactive dyestuffs of the formula ##STR1## wherein the substituents have the meaning given in the description, are particularly suitable for dyeing naturally occurring and synthetic materials containing OH groups and/or amide groups.
    Type: Grant
    Filed: January 26, 1993
    Date of Patent: May 2, 1995
    Assignee: Bayer Aktiengesellschaft
    Inventors: Thomas Eizenhofer, Wolfgang Harms, Karl-Josef Herd
  • Patent number: 5412137
    Abstract: A process for preparing compounds of the formula ##STR1## where X.sub.1 and X.sub.2 are independently O or S, andR.sub.1 is as defined herein,R.sub.2, R.sub.3, and R.sub.4 are each independently straight or branched chain (C.sub.1-4)alkyl,and pharmaceutically acceptable salts, physiological hydrolyzable esters, and pro-drug forms thereof, which are useful as hypoglycemic agents.
    Type: Grant
    Filed: February 16, 1994
    Date of Patent: May 2, 1995
    Assignee: Sandoz Ltd.
    Inventors: Mahavir Prashad, Prasad K. Kapa
  • Patent number: 5410041
    Abstract: The invention relates to fibre-reactive dyes of formula ##STR1## wherein the variables are as defined in the claims. These dyes are especially suitable for dyeing cellulosic fibre materials and produce dyeings of good tinctorial strength and good fastness properties.
    Type: Grant
    Filed: August 13, 1993
    Date of Patent: April 25, 1995
    Assignee: Ciba Geigy Corporation
    Inventor: Bernhard Muller
  • Patent number: 5409947
    Abstract: New therapeutic agents of cycloheptimidazole derivatives are disclosed, which are represented by the following formula or its alkali-addition salts. ##STR1## (wherein R.sub.1 represents H or isopropyl group; R.sub.2 represents a lower alkyl; R.sub.3 represents a carboxylic acid or tetrazole group. A and A.sub.1 are substituted groups at 4 or 8 position and A.sub.1 is a hydrogen or hydroxy group when A is a hydrogen or A and A.sub.1 is an oxo group. The dotted line "- - - -" is two double bonds or saturated single bonds).These compounds are useful as anti-hypertensive or anti-congestive heart failure agents.
    Type: Grant
    Filed: May 21, 1993
    Date of Patent: April 25, 1995
    Assignee: Kotobuki Seiyaku Co., Ltd.
    Inventors: Tsuyoshi Tomiyama, Akira Tomiyama, Takashi Yanagisawa, Naoto Ueyama, Tomoyuki Kawai, Motoharu Sonegawa, Hiromi Baba, Makoto Haketa
  • Patent number: 5409912
    Abstract: A new compound, which we have named Leustroducsin H, has formula (I): ##STR1## and pharmaceutically acceptable salts thereof. This compound may be prepared by hydrolysis of naturally occurring Leustroducsins and the compound may be used for the treatment or prophylaxis of thrombocytopenia.
    Type: Grant
    Filed: April 8, 1994
    Date of Patent: April 25, 1995
    Assignee: Sankyo Company, Limited
    Inventors: Yukio Sugimura, Tomoyuki Shibata, Kazuhiko Tamaki, Shinwa Kurihara, Takafumi Kohama, Akio Shiraishi, Tomowo Kobayashi, Kazuhiko Sasagawa, Naomi Shimazaki